America becomes cancer capital of the WORLD with more cases than all but one country
The US saw 2.4million new cases of cancer in 2022, surpassing all but China, which saw nearly 4.8million. However, the US saw a higher rate than the Asian country - 1,307 cases per 100,000 people, compared to China's 490 per 100,000.
Overall, the US has the fifth-highest cancer rate in the world, and cases are climbing.
America made up about 13 percent of the 19 million cases recorded worldwide in 2022, more than the combined share from all of Africa (six percent), Latin America and the Caribbean (seven percent), and Oceania (less than two percent).
And global diagnoses are only expected to increase, reaching 35million a year by 2050.
Lung cancer was the most commonly diagnosed among both men and women, responsible for almost 2.5 million new cases, or one in eight cancers worldwide. In the US, an estimated 236,740 new cases of lung cancer were diagnosed, and 130,000 people died.
Breast cancer in women made up 12 percent of cases worldwide, colorectal accounted for 10 percent, prostate at seven percent, and stomach at five percent.
Cancer is now the leading cause of death in Americans under 85, according to the American Cancer Society's 2024 report.
While it remains the second-leading cause of death overall in the US, it has surpassed heart disease as the top killer in younger age groups.
The anticipated spike in new cancer diagnoses is mainly due to population growth and aging, but experts are increasingly blaming environmental toxins and ultra-processed foods.
And though cancer rates among people under 50 are on the rise, particularly colorectal cancer, the disease still primarily afflicts seniors.
'This rise in projected cancer cases by 2050 is solely due to the aging and growth of the population, assuming current incidence rates remain unchanged,' Dr Hyuna Sung, senior principal scientist at the American Cancer Society, said.
'Notably, the prevalence of major risk factors such as consumption of unhealthy diet, physical inactivity, heavy alcohol consumption, and cigarette smoking are increasing in many parts of the world and will likely exacerbate the future burden of cancer barring any large scale interventions.'
Experts warn that the projected rise in cancer cases by 2050 stems from more than just aging populations.
Population growth explains part of the increase, but preventable risk factors —poor diet, lack of access to screenings, and chemical exposures — are also driving the disproportionate spikes.
While the US diagnoses about one in six global cancer cases, it accounts for just seven percent of deaths worldwide, thanks to advanced treatments and fast drug approvals.
The American Cancer Society reported that almost half of all cases and about 56 percent of cancer deaths in 2022 occurred in Asia, where over 59 percent of the world's population lives.
Cancer death rates in Africa and Asia are much higher than cases, partly because cancers there are often found late and are harder to treat.
Europe has more cancer cases and deaths than expected for its population, making up about 20 percent of global cases and deaths, though it has less than 10 percent of the world's people.
Prostate cancer in men is the most frequently diagnosed cancer in 118 countries, followed by lung cancer among both sexes in 33 countries, and liver, colorectal, and stomach cancer ranking in first place in 11, nine, and eight countries, respectively.
By 2050, lung cancer cases will climb from about 2.5 million in 2022 to roughly four million. Deaths will also climb from approximately 1.8 million to about three million.
Global breast cancer cases are projected to surge from 2.3 million to 3.5 million by 2050, with deaths rising from 666,000 to 1 million.
Breast cancer is the most common cancer in women (excluding skin cancer), diagnosed in 157 countries, while cervical cancer leads in 25 others. The US saw 288,000 new cases in 2022, with over 319,000 projected for 2025.
Just 10 cancer types cause over 60 percent of all cases and deaths globally. Leading the pack is lung cancer (12.4 percent of cases), followed by breast (11.6 percent), colorectal (9.6 percent), prostate (7.3 percent), and stomach cancers (4.9 percent).
Colorectal cancer cases will skyrocket from 1.9 million to 3 million globally by 2050, fueled by processed diets and rising early-onset cases. In 2023, 19,550 Americans under 50 were diagnosed with CRC.
Deaths will climb from 904,000 to 1.4 million, especially in regions with poor screening.
In North America, pancreatic cancer cases and deaths will both increase sharply, with minimal survival improvements expected. Obesity and diabetes are key drivers.
Prostate cancer is set to explode—from 1.5 million cases today to a staggering 2.5 million by 2050—as the world's population ages.
Deaths will leap from 397,000 to 600,000, hitting sub-Saharan Africa hardest, where life-saving treatments remain out of reach for millions.
Liver cancer cases will rise from 865,000 to 1.2 million. Deaths will remain high, nearing one million, due to late detection in poorer parts of the world.
It's on track to become more common, fueled by America's growing struggles with obesity, diabetes, and heavy drinking—even as hepatitis-linked cases fade. Deaths will climb in lockstep, as most patients are diagnosed too late for effective treatment.
Cervical cancer cases could plummet from 660,000 to 500,000 with wider HPV vaccination, yet deaths may persist in Africa without better screening. Meanwhile, North America could nearly eliminate it, thanks to vaccines and early detection.
Stomach cancer cases will decline slightly due to H. pylori control, but deaths will persist in regions with limited healthcare.
Pancreatic cancer cases will spike from 511,000 to 800,000, with deaths mirroring this rise due to poor survival rates.
Esophageal cancer cases will grow from 511,000 to 700,000, driven by obesity-related adenocarcinoma in wealthy nations.
While cases in the US are rising, deaths due to cancer are on the decline thanks to advances in treatments.
Scientists can now engineer immune cells in the lab that target and kill cancer cells, while CRISPR-based gene therapies have progressed from the lab to clinical trials for people with cancer.
Dr Karen E Knudsen, CEO of the American Cancer Society, said: 'Understanding the global cancer burden is critical to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer.
'This data provides insight into trends and potential areas for intervention and can help prioritize discovery efforts worldwide.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
12 minutes ago
- BBC News
Lung cancer screening programme rolled out in Norfolk and Suffolk
A pilot lung cancer screening programme, which the NHS said had helped save lives, was being rolled out to more scheme was first launched for smokers and ex-smokers aged between 55 and 74 in Great Yarmouth, Norfolk, in 2022, before being extended to Lowestoft, Suffolk. It will now be available across the whole of Norfolk and people screened out of 8,000 were diagnosed with lung cancer, with 70% discovered at an early and more treatable stage, according to the NHS Norfolk and Waveney Integrated Care Board (ICB)."We've already seen a fantastic response... and that's why we're pushing ahead to offer more people the check," said Dr Suzanne Phillips from the board. "We're rolling this out in stages to tens of thousands of people, so it's really important people wait to be contacted about their check and book it in when offered."Lung cancer usually doesn't have many symptoms in its early stages, so that's why it's important we proactively check people who might be at risk of developing it."As part of the project, assessments with a medic are carried out initially, and lung scans are then offered if could attend a launch event between 10:00 BST and 13:00 on Tuesday, 26 August at the TIC mobile unit in Sainsbury's car park on the Hardwick industrial estate in King's Lynn, where free health checks will be offered. Follow Norfolk news on BBC Sounds, Facebook, Instagram and X.
BBC News
13 minutes ago
- BBC News
Bristol NHS merger could create major health organisation
A potential merger between Bristol's hospital trusts could create one of the biggest healthcare organisations in the UK, says its chief Kane, head of both North Bristol NHS Trust and the University Hospitals Bristol and Weston (UHBW) NHS Foundation Trust, says operating as a single organisation will result in "better outcomes" for the 1.5million patients the two trusts merger would reduce the duplication of services and possibly lead to an expansion of services at Southmead Kane said: "I have seen huge appetite from our clinicians to want to come together around what's best for patients." The North Bristol NHS Trust runs sites including Southmead Hospital, while UHBW runs the Bristol Royal Infirmary (BRI), St Michael's, Bristol Children's Hospital, Weston General Hospital and potential partnership between the two trusts would strengthen collaboration across Bristol, North Somerset and South Kane explained she has discovered a wide variation in outcomes for some of the 44 services that are duplicated on both sites, including cardiac care."One of our clinicians talked about the unfairness of getting in an ambulance and being very worried about whether it would turn left or right, because they knew the outcome could be very different," she added. Ms Kane said she hoped the possible merger will create one of the biggest hospital trusts in the UK, second to Manchester which employs more than 28,000 health professionals, and may result in an expansion of services in Southmead."We are setting up a community participation group because whatever we do has to align to need and be acceptable to local people, which we have to do with a finite budget," she Kane said the trusts would be assessing how demand for inpatient services should dictate how different buildings are used, but said she acknowledged people would still like to access services in the city centre. Different waiting lists The trusts are already working closely in specialties including cardiac services - where waiting lists for some minimally-invasive heart procedures are nine months at Southmead, compared with just six weeks at the trusts are using a private company to send mini stick-on heart monitors to patients at home, which they can post back to get a result within just two weeks. University of Bristol student Katherine Barnes has benefitted from the closer working relationship between both hospital trusts. She was diagnosed with an irregular heartbeat earlier this year, and is one of the patients who has used a patch monitor. The 21-year-old competitive cyclist said: "I had been having arrhythmias off and on for about 10 years, but it came on really suddenly during one of the biggest races of the season and so I had to pull out. "I received the patch in a recent appointment and I just sent it back to them and they analysed the data for me." The merger is also improving collaborations in research, including a potential cure for the rare kidney disease, IgA of paediatric nephrology at the University Hospitals Bristol, Moin Saleem, is teaming up with clinicians from Southmead to start a world-first study using gene therapy, which uses a virus to introduce genetic material into the IgA cell to cure them of the disease."The significance we hope will be pretty huge because at the moment there is no curative therapy for this disease," said Prof Saleem."If this switches off the disease then those patients will be able to avoid dialyses completely."Richard Betteridge has IgA nephropathy and hopes to go on the trial. The 32-year-old said: "It really does give you that sense of hope that there's something you can do, and you are also contributing to advancing the science around the management of this condition." Following the Government's 10-year plan, announced in July, a network of local health hubs will be created and Ms Kane added this move will allow them to transfer services to community health hubs, creating opportunities for staff to build new relationships and broaden and UHBW is already seeing an extra 70,000 patients a year through two community diagnostic centres in Cribbs Causeway and Weston-super-Mare and the long-term plan is for more patients to be seen and treated closer to home.
BBC News
43 minutes ago
- BBC News
'Our son was injured in rugby, but he had cancer'
"Harrison has soldiered on. He is a warrior, a real champion. I'm so proud," says dad Mitchell of his son, who has been diagnosed with 13-year-old, from Leicester, first complained of back pain after he was injured while playing rugby at school in December last year - but, as time went on, it got worse and he was forced to give up playing football for his team, Thurmaston Magpies, in family were told the following month that he had multiple tumours - in his spine, spleen, stomach, liver, lung and parents are now planning an event to raise money to pay for future treatment for their son, as well as to support other children with cancer. When Harrison's pain worsened, his mum Lindzey, 34, says the family "instinctively knew there was something possibly seriously wrong".During initial visits to A&E, the family say they were told the teenager might be suffering from growing pains or something Lindzey says that "didn't fit with what we were seeing with Harrison" and so, in March, they insisted he was admitted to hospital for tests.A subsequent MRI scan confirmed Harrison had family say they were initially told he had germ cell cancer, but his dad, Mitchell, 36, says they have now been told it is likely to be another rare form of the are continuing to determine what type of cancer Harrison has and his prognosis is currently unknown. Harrison has undergone four rounds of chemotherapy, which Mitchell says has stabilised the tumours."We are hoping the latest one is a lot stronger and will shrink his tumours," he adds."But we know there are no certainties."Harrison says he has had "some really good days off chemotherapy and then some really bad days", adding: "Food can taste strange and some drinks feel fizzy when they are really not."The Leicester City season ticketholder is being supported through his treatment by his two younger brothers, aged nine and in April, Harrison received a visit from his favourite Leicester City player, Kasey McAteer, who stopped by the family home to wish him well with his says: "He gave me some boots he signed. They are really nice."What a lovely present. It made my day." Mitchell says the family has been "overwhelmed with support from the local community".They will hold a community fun day at Birstall United FC on 30 August - the proceeds of which the family say will be used to support Harrison, while some of the money raised will be used to support Ward 27 at Leicester Royal Infirmary and cancer family say the care Harrison has received following his diagnosis has been "fantastic", but they question whether his condition could have been picked up sooner and have complained to the trust about says: "It's been a hell of a journey."Gang Xu, deputy medical director at the University Hospitals of Leicester NHS Trust, says: "We know this is an incredibly difficult time for Harrison and his family, and we understand they have questions around his diagnosis."We are working closely with the family to help provide answers."We also want to extend our heartfelt thanks for their efforts to help raise money to support other children being treated for cancer."Fundraising like this can make a real difference to young patients and their families."
